Arcellx vs BioStem Technologies (OTC: BSEM)
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
121 employees · est. 2015 · Redwood City, United States
-logo.jpg "BioStem Technologies (OTC: BSEM)"){kind=logo}
BioStem Technologies (OTC: BSEM)
We Manufacture Products That Change Lives
47 employees · est. 2014 · Pompano Beach, United States
BioStem Technologies (OTC: BSEM) is the older company (2015 vs 2014); Arcellx is the larger of the two.
Side-by-Side Comparison
| Metric | Arcellx | BioStem Technologies (OTC: BSEM) |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2014 older |
| Headquarters | ||
| Headquarters | Redwood City, United States | Pompano Beach, United States |
| Employees | ||
| Employees | 121 larger | 47 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Acquired | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $8.43B | $2.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 1 |
| Services | ||
| Services | Cell Therapy Development, Clinical Trials Execution, Therapy Manufacturing, Research for Novel Therapies | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer Patients, Healthcare Providers, Medical Researchers, Investors in Biotechnology | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Clinical-stageCell TherapyImmunotherapyCancer TreatmentMultiple MyelomaAcute Myeloid Leukemia +8 | Regenerative MedicinePerinatal TissueAllograftsBioRetain ProcessingGrowth Factors PreservationQuality Management +6 |
| Website | ||
| Website | arcellx.com | biostemtechnologies.com |
About Arcellx
Arcellx, founded in 2015, is a clinical-stage biotechnology company headquartered in the United States. Specializing in biopharma, biotechnology, health care, life sciences, and pharmaceuticals, the company has made significant strides in the realm of cell therapy. As of its last major development,...
About BioStem Technologies (OTC: BSEM)
BioStem Technologies (OTC: BSEM) is a leading innovator in the biotechnology and pharmaceutical industries, specializing in the development, manufacture, and commercialization of allografts for regenerative therapies. The company's BioRetain processing method is at the core of its focus on manufactu...
Also comparing in this category
Comparing more than these two?
Get Arcellx, BioStem Technologies (OTC: BSEM) and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Arcellx compare?
A PDF of Arcellx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Arcellx with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Arcellx on 3 Jul 2026, and BioStem Technologies (OTC: BSEM) on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
